fbpx

Alzheimer’s

Alzheimer’s Disease and Brain Photobiomodulation | Clinical Results with Vielight Neuro

Alzheimer’s Disease and Brain Photobiomodulation | Mechanisms and Clinical Results with Vielight Neuro Alzheimer's disease (AD) remains one of the most challenging and devastating neurodegenerative conditions affecting millions worldwide. Characterized by progressive cognitive decline, memory loss, and behavioral changes, AD not only affects the individual but also imposes a significant burden on caregivers and [...]

Vielight Featured in USA Today!

Vielight featured in USA Today for Alzheimer's and Parkinsons' Research! We were recently featured in USA Today! This independent article covers the modern day challenges that humanity faces and how our Vielight Neuro is being used in cutting-edge photobiomodulation research to study the effects of optimized, high-powered NIR energy delivery to the brain. This [...]

Brain Photobiomodulation: A Potential Drug-Free Option for Alzheimer’s Therapy

Brain Photobiomodulation: A Drug-Free Alternative for Treating Alzheimer's Disease Alzheimer's disease, a progressive neurodegenerative disorder, poses one of the greatest challenges to modern medicine. With its devastating impact on cognitive function and quality of life, finding effective treatments has become an urgent priority. As traditional pharmacological therapies struggle to provide a definitive cure, alternative [...]

40Hz Gamma Neuromodulation in Alzheimer’s Research | Brain Photobiomodulation and Visual Cortex Stimulation

The Ongoing Search for Effective and Accessible Treatments for Alzheimer’s Disease Alzheimer’s disease (AD) is the most common type of dementia in elderly individuals worldwide (Wilson et al., 2012). The disease is characterized by neurodegeneration, tissue changes in the brain, (including amyloid-containing plaques and tangles of hyperphosphorylated tau protein), severe cognitive decline and in [...]

Dementia and Brain Photobiomodulation

In 2015, our dementia pilot trial made history by being the first to show efficacy of brain photobiomodulation (PBM) for dementia in humans with a home-use device, the Vielight Neuro Gamma.[1] In 2019, Dr. Linda Chao, a professor in the Departments of Radiology, Biomedical Imaging and Psychiatry at the University of California, verified our [...]